Insider Transactions in Q1 2025 at Oncology Institute, Inc. (TOI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2025
|
Yale Podnos Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
157,088
+39.95%
|
-
|
|
Mar 31
2025
|
Robert Ross Carter Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
197,368
+45.46%
|
-
|
|
Mar 31
2025
|
Jeremy Castle Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
162,281
+39.11%
|
-
|
|
Mar 31
2025
|
Daniel Virnich Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,083,334
+37.47%
|
-
|
|
Mar 26
2025
|
M33 Growth I L.P. Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,716,898
+14.2%
|
$2,716,898
$1.04 P/Share
|
|
Mar 26
2025
|
Daniel Virnich Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
22,640
+3.03%
|
$22,640
$1.04 P/Share
|
|
Mar 26
2025
|
Yale Podnos Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
9,056
+10.28%
|
$9,056
$1.04 P/Share
|
|
Mar 26
2025
|
Mark L Pacala Director |
BUY
Open market or private purchase
|
Indirect |
90,562
+28.7%
|
$90,562
$1.04 P/Share
|
|
Mar 26
2025
|
Brad Hively Director |
BUY
Open market or private purchase
|
Direct |
9,056
+1.32%
|
$9,056
$1.04 P/Share
|
|
Mar 26
2025
|
Karen Marie Johnson Director |
BUY
Open market or private purchase
|
Direct |
36,224
+15.12%
|
$36,224
$1.04 P/Share
|
|
Mar 26
2025
|
Jeremy Castle Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
9,056
+9.11%
|
$9,056
$1.04 P/Share
|
|
Mar 26
2025
|
Richard A Barasch Director |
BUY
Open market or private purchase
|
Indirect |
1,358,448
+43.34%
|
$1,358,448
$1.04 P/Share
|
|
Mar 26
2025
|
Robert Ross Carter Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
9,056
+18.69%
|
$9,056
$1.04 P/Share
|
|
Mar 19
2025
|
Daniel Virnich Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,261
-1.44%
|
$0
$0.89 P/Share
|
|
Mar 19
2025
|
Robert Ross Carter Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,150
-3.65%
|
$0
$0.89 P/Share
|
|
Mar 19
2025
|
Yale Podnos Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,975
-4.08%
|
$0
$0.89 P/Share
|
|
Jan 06
2025
|
Robert Ross Carter Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
258
-0.81%
|
$0
$0.34 P/Share
|